▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Maxx Chatsko

XMFBlacknGoldX

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent Articles by Maxx Chatsko

stock down erased chalkboard

Feb 25, 2020 by Maxx Chatsko

Here's Why Guardant Health Tumbled Today

The company expects losses to more than double in 2020, which caught Wall Street analysts by surprise.

stock sliding chalkboard

Feb 24, 2020 by Maxx Chatsko

Here's Why Clovis Oncology Lost as Much as 11.8% Today

Investors are nervous heading into the company's fourth-quarter and full-year 2019 earnings report.

chalkboard stock down pink

Feb 24, 2020 by Maxx Chatsko

Here's Why Epizyme Is Tumbling Today

The pharma company released full-year 2019 operating results.

031 lithium brine

Feb 24, 2020 by Maxx Chatsko

Lithium: 3 Things Investors Need to Know

Lithium is bound to be one of the most important materials of the 21st century. Is your portfolio positioned for the opportunity?

raining cash getty

Feb 21, 2020 by Maxx Chatsko

Here's Why Aerie Pharmaceuticals Jumped as Much as 14.4% Today

The eye-care company reported better-than-expected fourth-quarter 2019 product revenue.

multiple lines down

Feb 21, 2020 by Maxx Chatsko

Here's Why Livent Stock Tumbled Today

The lithium producer disappointed investors with initial full-year 2020 guidance and production delays, but its long-term potential remains intact.

063 2019 blocks

Feb 21, 2020 by Maxx Chatsko

Repligen Signals Gene Therapy Strength With 2019 Earnings Report

Guidance for 2020 appears to have spooked investors, but the bioprocess leader is on a solid long-term trajectory.

chalkboard stock down pink

Feb 20, 2020 by Maxx Chatsko

Here's Why Agenus Tumbled Today

Results from an experimental combination therapy were impressive, but they might not be impressive enough.

business growth

Feb 20, 2020 by Maxx Chatsko

Here's Why Albemarle Rose as Much as 11.6% Today

Investors cheered the company's fourth-quarter and full-year 2019 earnings report.

businessman pulley stock down

Feb 20, 2020 by Maxx Chatsko

Here's Why Invitae Stock Is Tumbling Today

The genetic testing company reported full-year 2019 operating results.

076 arrow dude getty

Feb 20, 2020 by Maxx Chatsko

Here's Why Twist Bioscience Stock Rose as Much as 14.8% Today

The company announced a public offering of common stock.

paper airplanes rising

Feb 19, 2020 by Maxx Chatsko

Here's Why SunPower Is Soaring Today

An industry peer echoed SunPower's previous comments that, at this time, the coronavirus epidemic in China isn't expected to have a major impact on first-quarter 2020 operations.

arrow up shelves

Feb 19, 2020 by Maxx Chatsko

Agenus Stock Rises Ahead of Investor Day Presentation

The biopharma is scheduled to update investors and Wall Street analysts on two important pipeline programs on Feb. 20.

woman orange laptop excited

Feb 19, 2020 by Maxx Chatsko

Here's Why Enphase Energy Stock Is Soaring Today

The solar hardware company reported full-year 2019 operating results.

600 scientist microscope

Feb 18, 2020 by Maxx Chatsko

Here's Why Inovio Pharmaceuticals Popped Today

The pharmaceutical company received a lot of positive media attention over the weekend.

353 doctor boxing gloves

Feb 15, 2020 by Maxx Chatsko

2 Top Stocks Under $20

These pharma stocks have gone in different directions in the last year, but both hold promise for forward-thinking investors.

302 yellow airplane unique

Feb 14, 2020 by Maxx Chatsko

About to Buy Penny Stocks? Look at These 2 Companies First

These healthcare stocks offer high risk and high reward, but they aren't nearly as risky as penny stocks.

multiple lines down

Feb 13, 2020 by Maxx Chatsko

Here's Why Avrobio Fell as Much as 16.4% Today

The small-cap biopharmaceutical company announced a public stock offering.

chalkboard stock down pink

Feb 13, 2020 by Maxx Chatsko

Here's Why Deciphera Pharmaceuticals Tumbled Today

The company announced a public stock offering as it prepares for a potential regulatory approval in 2020.

297 head in sand

Feb 19, 2020 by Maxx Chatsko

Twist Bioscience Pursues Growth at All Costs. How Long Will Investors Tolerate It?

The biggest source of uncertainty has been removed, allowing Wall Street to focus on the company's growth and financials. But investors should be careful what they wish for.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services